Demonstration highlights improved efficiency in cell therapy processes, suggesting Cocoon platform may enhance production scales.
Watch the demonstration video or read the poster to learn how the Cocoon® platform streamlines patient-scale cell therapy manufacturing by minimizing manual touchpoints at every stage: Sample loading, Activation, Transduction or transfection, Expansion, Harvest. About the speaker: Joseph O’Connor, PhD, is currently a senior scientist in process development for Lonza’s Personalized Medicine Business Unit. His focus is on translating and optimizing manual autologous cell therapies into the Cocoon® Platform, a closed and automated cell therapy manufacturing solution. Joseph earned a doctorate in chemical engineering from the Pennsylvania State University while researching the mechanical regulation of gene expression. He has been with Lonza since 2017.
No takes yet. Share an insight, caveat, or question.
Joseph O’Connor (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: